Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.35 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.35 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27524606 | 1.00 | MEN1 (0.47) | MEN1KMT2ANR1I2RAB9ASMN1; SMN2 | |
| SCHEMBL27888314 | 0.88 | MEN1 (0.39) | MEN1KMT2ANR1I2RAB9ASMN1; SMN2 | |
| SCHEMBL2425468 | 0.88 | MEN1 (0.39) | MEN1KMT2ANR1I2RAB9ASMN1; SMN2 | |
| SCHEMBL10771505 | 0.86 | TDP1 (0.41) | MEN1KMT2ANR1I2RAB9ASMN1; SMN2 | |
| SCHEMBL2418975 | 0.85 | ALDH1A1 (0.41) | MEN1KMT2ANR1I2RAB9AALDH1A1 | |
| SCHEMBL27237502 | 0.85 | MEN1 (0.45) | MEN1KMT2ANR1I2RAB9ASMN1; SMN2 | |
| SCHEMBL3683230 | 0.85 | MEN1 (0.45) | MEN1KMT2ANR1I2RAB9ASMN1; SMN2 | |
| SCHEMBL27820949 | 0.85 | MEN1 (0.34) | MEN1KMT2A | |
| SCHEMBL10772381 | 0.84 | LMNA (0.43) | MEN1KMT2ARAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL22335 | 0.83 | MEN1 (0.37) | MEN1KMT2ANR1I2RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 845 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025202325-A1 | POLYPROPYLENE COMPOSITION FOR CABLE INSULATION | BOREALIS GMBH (AT) | 2025-10-02 | — | — | WO | claimed |
| WO-2025202306-A1 | POLYPROPYLENE COMPOSITION FOR CABLE INSULATION | BOREALIS GMBH (AT) | 2025-10-02 | — | — | WO | claimed |
| WO-2025067703-A1 | POLYOLEFIN COMPOSITION FOR CABLE INSULATION | BOREALIS AG (AT) | 2025-04-03 | — | — | WO | claimed |
| US-10081726-B2 | Composite comprising a cellulose-based filler | BOREALIS AG (AT) | 2018-09-25 | — | — | US | claimed |
| US-20180215908-A1 | COMPOSITE COMPRISING A CELLULOSE-BASED FILLER | BOREALIS AG (AT) | 2018-08-02 | — | — | US | claimed |
| EP-3325555-A1 | COMPOSITE COMPRISING A CELLULOSE-BASED FILLER | Borealis AG (AT) | 2018-05-30 | — | — | EP | claimed |
| WO-2017029181-A1 | COMPOSITE COMPRISING A CELLULOSE-BASED FILLER | BOREALIS AG (AT) | 2017-02-23 | — | — | WO | claimed |
| US-20100160518-A1 | Controlled Nucleated Polymer Composition | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2010-06-24 | — | — | US | claimed |
| WO-2007107579-A1 | A CONTROLLED NUCLEATED POLYMER COMPOSITION | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2007-09-27 | — | — | WO | claimed |
| EP-4473055-B1 | POLYOLEFIN BLEND CONTAINING RECYCLED ALUMINIUM | INEOS EUROPE AG (CH) | 2026-04-08 | — | — | EP | disclosed |
| US-20260085177-A1 | POLYPROPYLENE COMPOSITION FOR CABLE INSULATION | BOREALIS AG (AT) | 2026-03-26 | — | — | US | disclosed |
| EP-3461859-B1 | REINFORCED POLYMER COMPOSITION | BOREALIS GMBH (AT) | 2026-01-21 | — | — | EP | disclosed |
| EP-3180399-B1 | TERPOLYMER COMPOSITIONS WITH IMPROVED CLARITY AND GLOSS | EQUISTAR CHEM LP (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20260001976-A1 | A PROPYLENE-ETHYLENE RANDOM COPOLYMER FOR PIPE APPLICATIONS | BOREALIS AG (AT) | 2026-01-01 | — | — | US | disclosed |
| WO-2004099032-A1 | TRANSPARENT POLYPROPYLENE CONTAINERS FOR PACKAGING SHOES | BASELL POLYOLEFINE GMBH (DE) | 2004-11-18 | — | — | WO | disclosed |
| WO-2003106523-A1 | FLEXIBLE PROPYLENE COPOLYMER COMPOSITIONS HAVING A HIGH TRANSPARENCY | BASELL POLYOLEFINE GMBH (DE) | 2003-12-24 | — | — | WO | disclosed |
| WO-2003106553-A1 | PROPYLENE COPOLYMER COMPOSITIONS HAVING A GOOD LOW-TEMPERATURE IMPACT TOUGHNESS AND A HIGH TRANSPARENCY | BASELL POLYOLEFINE GMBH (DE) | 2003-12-24 | — | — | WO | disclosed |
| EP-0860457-B1 | Polypropylene block copolymers and containers made therefrom | POLYPROPYLENE BELGIUM NV (BE) | 2003-04-16 | — | — | EP | disclosed |
| US-6159567-A | Polypropylene block copolymers and containers made therefrom | SOLVAY POLYOLEFINS EUROPE-BELGIUM (SOCIETE ANONYME) (BE) | 2000-12-12 | — | — | US | disclosed |
| EP-0860457-A1 | Polypropylene block copolymers and containers made therefrom | SOLVAY POLYOLEFINS EUROPE - BELGIUM (Société Anonyme) (BE) | 1998-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085177-A1 | POLYPROPYLENE COMPOSITION FOR CABLE INSULATION | MPC2, CRHR2, NPY2R | MEN1 916/4885KMT2A 4614/4885NR1I2 1161/4885 |
| US-20260001976-A1 | A PROPYLENE-ETHYLENE RANDOM COPOLYMER FOR PIPE APPLICATIONS | PEX3, MPC2, LBR | MEN1 2602/4885KMT2A 4880/4885NR1I2 682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.